Skip to main content

Table 3 Antimicrobial susceptibility pattern according to methicillin resistance

From: Epidemiology and antimicrobial susceptibility of Staphylococcus aureus in children in a tertiary care pediatric hospital in Milan, Italy, 2017—2021

  Cotrimoxazole Clindamycin Macrolides Linezolid Daptomycin Levofloxacin Fusidic Acid Mupirocin Gentamicin Tetracyclin Vancomycin
MRSA S 56 (74) 53 (70) 46 (60) 75 (99) 72 (95) 40 (53) 47 (62) 68 (89) 50 (66) 57 (75) 76 (100)
R 17 (22) 18 (24) 28 (37) 0 (0) 1 (1) 35 (46) 26 (34) 6 (8) 25 (33) 15 (20) 0 (0)
I 2 (3) 4 (5) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 4 (5) 0 (0)
NT 1 (1) 1 (1) 2 (3) 1 (1) 3 (4) 1 (1) 3 (4) 2 (3) 1 (1) 0 (0) 0 (0)
MSSA S 166 (93) 149 (83) 144 (80) 175 (98) 175 (98) 163 (91) 162 (90) 165 (92) 164 (92) 166 (93) 176 (100)
R 11 (6) 25 (14) 31 (17) 0 (0) 0 (0) 11 (6) 11 (6) 8 (4) 10 (6) 8 (4) 0 (0)
I 0 (0) 3 (2) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
NT 2 (1) 2 (1) 4 (2) 4 (2) 4 (2) 5 (3) 6 (3) 6 (3) 5 (3) 5 (3) 0 (0)
P-value  < 0.01 0.03  < 0.01 1 0.3  < 0.01  < 0.01 0.4  < 0.01  < 0.01 1
  1. Data are presented as numbers (percentages)
  2. MRSA Methicillin-resistant Staphylococcus aureus, MSSA Methicillin-susceptible Staphylococcus aureus, S Sensible, R Resistant, I Intermediate, NT Not tested